The introduction of incretin based therapies, particularly glucagon like peptide 1 receptor agonists, represented a major advance in the management of metabolic disease
Vaccines are not considered an injectable medication
The Future of Fame: Inside TIME's 2026 TIME100 Creators List TIME Editorial Director Lucy Feldman breaks down the 2026 TIME100 Creators list, the evolution of the creator economy, and what's next for digital media
SLU-PP-332 is a novel and powerful estrogen-related receptor (ERR) agonist, specifically targeting ERR, ERR, and ERR
In recent years, other dual or triple receptor agonists have been developed by the pharmaceutical industry besides tirzepatide (64)
Early on, a dose that's a few days past expiration may retain 95% of its strength